---
title: "Ivacaftor - Cystic Fibrosis Of The Lung"
sidebar: mydoc_sidebar
permalink: db08820-mesh-d003550-1.html
toc: false 
---


Path ID: `DB08820_MESH_D003550_1`
{% include image.html url="images/db08820-mesh-d003550-1.png" file="db08820-mesh-d003550-1.png" alt="db08820-mesh-d003550-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:C545203">MESH:C545203 </a> | Ivacaftor | Drug |
| <a href="https://identifiers.org/UniProt:P13569">UniProt:P13569 </a> | Cystic fibrosis transmembrane conductance regulator | Protein |
| <a href="https://identifiers.org/MESH:D003550">MESH:D003550 </a> | Cystic fibrosis of the lung | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Ivacaftor | INCREASES ACTIVITY OF | Cystic Fibrosis Transmembrane Conductance Regulator |
| Cystic Fibrosis Transmembrane Conductance Regulator | DISRUPTED BY | Cystic Fibrosis Of The Lung |
|---------|-----------|---------|

Comment: Ivacaftor as monotherapy has failed to show a benefit for patients with delta-F508 mutations

Reference: 
  - [https://go.drugbank.com/drugs/DB08820](https://go.drugbank.com/drugs/DB08820)
